Company Information for AUTIFONY THERAPEUTICS LIMITED
STEVENAGE BIOSCIENCE CATALYST, GUNNELS WOOD ROAD, STEVENAGE, HERTFORDSHIRE, SG1 2FX,
|
Company Registration Number
07543962
Private Limited Company
Active |
Company Name | ||
---|---|---|
AUTIFONY THERAPEUTICS LIMITED | ||
Legal Registered Office | ||
STEVENAGE BIOSCIENCE CATALYST GUNNELS WOOD ROAD STEVENAGE HERTFORDSHIRE SG1 2FX Other companies in SW7 | ||
Previous Names | ||
|
Company Number | 07543962 | |
---|---|---|
Company ID Number | 07543962 | |
Date formed | 2011-02-25 | |
Country | ENGLAND | |
Origin Country | United Kingdom | |
Type | Private Limited Company | |
CompanyStatus | Active | |
Lastest accounts | 30/09/2022 | |
Account next due | 30/06/2024 | |
Latest return | 25/02/2016 | |
Return next due | 25/03/2017 | |
Type of accounts | GROUP | |
VAT Number /Sales tax ID |
Last Datalog update: | 2024-04-06 21:06:16 |
Companies House |
Menu
|
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |
Officer | Role | Date Appointed |
---|---|---|
JOHN BERRIMAN |
||
CATHERINE ELIZABETH BINGHAM |
||
IP2IPO SERVICES LIMITED |
||
ELAINE JONES |
||
CHARLES LARGE |
||
ATUL PANDE |
Officer | Role | Date Appointed | Date Resigned |
---|---|---|---|
BOBBY G. SONI |
Director | ||
MAINA BHAMAN |
Director | ||
ALLAN BAXTER |
Director | ||
GIUSEPPE ALVARO |
Director | ||
OLSWANG COSEC LIMITED |
Company Secretary | ||
CHRISTOPHER ALAN MACKIE |
Director | ||
OLSWANG DIRECTORS 1 LIMITED |
Director | ||
OLSWANG DIRECTORS 2 LIMITED |
Director |
Officer | Related Company | Role | Date Appointed | Role Status | Incorporation date | Company Status |
---|---|---|---|---|---|---|
TREX BIO LIMITED | Director | 2018-01-30 | CURRENT | 2018-01-30 | Liquidation | |
BICYCLE THERAPEUTICS PLC | Director | 2017-12-04 | CURRENT | 2017-10-27 | Active | |
BICYCLETX LIMITED | Director | 2017-12-04 | CURRENT | 2017-10-27 | Active | |
SITRYX THERAPEUTICS LIMITED | Director | 2017-02-01 | CURRENT | 2016-09-08 | Active | |
PULMOCIDE LIMITED | Director | 2013-10-31 | CURRENT | 2007-03-23 | Active | |
CALCHAN HOLDINGS LIMITED | Director | 2011-10-03 | CURRENT | 2011-02-25 | Liquidation | |
BICYCLERD LIMITED | Director | 2009-12-07 | CURRENT | 2009-07-13 | Active | |
SV HEALTH INVESTORS UK LIMITED | Director | 2004-09-20 | CURRENT | 2004-09-20 | Active | |
CONCIRRUS LTD | Director | 2018-07-23 | CURRENT | 2011-09-30 | Active | |
ARTIOS PHARMA LIMITED | Director | 2018-06-25 | CURRENT | 2015-12-29 | Active | |
CRYSALIN LIMITED | Director | 2018-06-21 | CURRENT | 2007-04-27 | Liquidation | |
SILICON MICROGRAVITY LIMITED | Director | 2018-06-06 | CURRENT | 2014-09-16 | Active | |
IESO DIGITAL HEALTH LIMITED | Director | 2018-04-26 | CURRENT | 2000-09-01 | Active | |
PERACHEM HOLDINGS PLC | Director | 2018-04-26 | CURRENT | 2005-04-15 | Liquidation | |
NEXEON LIMITED | Director | 2018-04-18 | CURRENT | 2006-02-22 | Active | |
EPSILON-3 BIO LIMITED | Director | 2018-04-16 | CURRENT | 2010-06-18 | Liquidation | |
APCINTEX LIMITED | Director | 2018-04-05 | CURRENT | 2014-06-16 | Active | |
KUUR THERAPEUTICS LIMITED | Director | 2018-03-28 | CURRENT | 2005-11-11 | Liquidation | |
OXFORD BIOTRANS LIMITED | Director | 2018-03-27 | CURRENT | 2013-08-14 | Active | |
OXULAR LIMITED | Director | 2018-03-27 | CURRENT | 2014-11-27 | Active | |
WAVE OPTICS LIMITED | Director | 2018-03-26 | CURRENT | 2012-09-05 | Active | |
TELECTICA LTD | Director | 2018-03-22 | CURRENT | 2012-12-11 | Active | |
TEYA REWARDS LTD. | Director | 2018-03-21 | CURRENT | 2013-05-03 | Active | |
IMPRESSION TECHNOLOGIES LIMITED | Director | 2018-03-13 | CURRENT | 2012-03-30 | Active | |
COVENTRY INTERNATIONAL PRESSING COMPANY LTD | Director | 2018-03-13 | CURRENT | 2015-02-02 | Active | |
PULMOCIDE LIMITED | Director | 2018-03-12 | CURRENT | 2007-03-23 | Active | |
CARDIAN LIMITED | Director | 2018-03-12 | CURRENT | 2016-12-21 | Liquidation | |
INIVATA LIMITED | Director | 2018-03-07 | CURRENT | 2014-07-23 | Active | |
SAM LABS LTD. | Director | 2018-02-28 | CURRENT | 2014-04-23 | Active | |
MISSION THERAPEUTICS LIMITED | Director | 2018-02-15 | CURRENT | 2011-05-11 | Active | |
STORM THERAPEUTICS LIMITED | Director | 2018-02-14 | CURRENT | 2015-04-21 | Active | |
ECONIC TECHNOLOGIES LTD | Director | 2018-02-14 | CURRENT | 2011-06-24 | Active | |
SPIREA LIMITED | Director | 2017-12-14 | CURRENT | 2015-10-09 | Active | |
MOA TECHNOLOGY LIMITED | Director | 2017-10-25 | CURRENT | 2017-08-02 | Active | |
PANCREGENESIS LIMITED | Director | 2017-10-17 | CURRENT | 2017-10-17 | Active - Proposal to Strike off | |
QUANTUM MOTION TECHNOLOGIES LIMITED | Director | 2017-08-11 | CURRENT | 2017-07-14 | Active | |
CHROMOSOL LIMITED | Director | 2017-06-09 | CURRENT | 2017-06-09 | Liquidation | |
EDGETIC LIMITED | Director | 2017-05-15 | CURRENT | 2017-05-15 | Liquidation | |
ALESI SURGICAL LIMITED | Director | 2017-03-02 | CURRENT | 2007-03-01 | Active | |
ART OF XEN LIMITED | Director | 2017-02-22 | CURRENT | 2001-06-15 | Active | |
ACCELERCOMM LTD | Director | 2016-12-21 | CURRENT | 2016-03-04 | Active | |
MICROBIOTICA LIMITED | Director | 2016-12-15 | CURRENT | 2016-07-08 | Active | |
CELLTRON NETWORKS LIMITED | Director | 2016-10-19 | CURRENT | 2016-10-19 | Active - Proposal to Strike off | |
APERIO PHARMA LIMITED | Director | 2016-10-13 | CURRENT | 2016-10-13 | Active - Proposal to Strike off | |
MIXERGY LIMITED | Director | 2016-08-26 | CURRENT | 2014-07-18 | Active | |
UNIPHY LIMITED | Director | 2016-07-11 | CURRENT | 2016-02-12 | Active | |
DYNAMIC VISION SYSTEMS LIMITED | Director | 2016-07-07 | CURRENT | 2014-10-07 | Active - Proposal to Strike off | |
ULTRALEAP HOLDINGS LIMITED | Director | 2016-06-13 | CURRENT | 2016-03-08 | Active | |
DEFENITION LIMITED | Director | 2016-05-11 | CURRENT | 2016-05-11 | Active | |
CERYX MEDICAL LIMITED | Director | 2016-05-03 | CURRENT | 2016-02-12 | Active | |
PULMONIR LIMITED | Director | 2016-03-15 | CURRENT | 2016-02-02 | Active - Proposal to Strike off | |
ASTERION LIMITED | Director | 2016-03-08 | CURRENT | 2000-12-21 | Active | |
FLUID PHARMA LTD | Director | 2016-03-03 | CURRENT | 2016-03-03 | Active | |
ZEETTA NETWORKS LIMITED | Director | 2015-12-22 | CURRENT | 2015-01-20 | Active | |
NAVENIO LIMITED | Director | 2015-12-04 | CURRENT | 2015-10-28 | Active | |
ADJUVANTIX LIMITED | Director | 2015-10-09 | CURRENT | 1999-10-28 | Dissolved 2016-07-12 | |
RELITECT LIMITED | Director | 2015-02-20 | CURRENT | 2014-11-17 | Active - Proposal to Strike off | |
8POWER LIMITED | Director | 2015-01-20 | CURRENT | 2015-01-20 | Active | |
PHASE FOCUS LIMITED | Director | 2014-12-17 | CURRENT | 2006-06-23 | Active | |
ULTRAMATIS LIMITED | Director | 2014-11-19 | CURRENT | 2014-11-19 | Active - Proposal to Strike off | |
DUKOSI LIMITED | Director | 2014-11-19 | CURRENT | 2003-11-27 | Active | |
MAGNOMATICS LIMITED | Director | 2014-11-07 | CURRENT | 2006-07-17 | Active | |
PERPETUUM LIMITED | Director | 2014-10-01 | CURRENT | 2004-06-04 | Active - Proposal to Strike off | |
EIGHT19 LIMITED | Director | 2014-09-22 | CURRENT | 2010-07-22 | Active | |
UMIP PROJECT 001 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Dissolved 2016-09-06 | |
UMIP PROJECT 003 LIMITED | Director | 2014-07-29 | CURRENT | 2014-07-29 | Active - Proposal to Strike off | |
BOXARR LIMITED | Director | 2014-07-24 | CURRENT | 2003-08-20 | Active | |
EXTRAJECT TECHNOLOGIES LTD | Director | 2014-07-23 | CURRENT | 2013-01-21 | Active | |
MEDELLA THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2007-02-08 | Active - Proposal to Strike off | |
PH THERAPEUTICS LIMITED | Director | 2014-07-23 | CURRENT | 2013-03-06 | Active | |
UMIP PROJECT 002 LIMITED | Director | 2014-07-03 | CURRENT | 2014-07-03 | Dissolved 2017-10-17 | |
CREAVO MEDICAL TECHNOLOGIES LIMITED | Director | 2014-04-01 | CURRENT | 2014-01-31 | Liquidation | |
OXSYBIO LIMITED | Director | 2014-03-03 | CURRENT | 2014-03-03 | Liquidation | |
IONIX ADVANCED TECHNOLOGIES LTD | Director | 2013-12-23 | CURRENT | 2011-08-04 | Active | |
SAW DX LIMITED | Director | 2013-08-12 | CURRENT | 2013-03-11 | Active - Proposal to Strike off | |
SPINETIC ENERGY LIMITED | Director | 2013-05-24 | CURRENT | 2012-05-28 | Liquidation | |
UBIQUIGENT LTD | Director | 2013-04-04 | CURRENT | 2009-07-10 | Active | |
AZURI TECHNOLOGIES LTD | Director | 2012-12-21 | CURRENT | 2012-07-10 | Active | |
PHOTOPHARMICA LIMITED | Director | 2012-12-21 | CURRENT | 2012-12-03 | Dissolved 2018-06-12 | |
OXEHEALTH LIMITED | Director | 2012-09-13 | CURRENT | 2012-07-31 | Active | |
OXFORD DRUG DESIGN LIMITED | Director | 2012-07-10 | CURRENT | 2001-10-17 | Active | |
CRYPTOGRAPHIQ LIMITED | Director | 2012-06-25 | CURRENT | 2012-06-25 | Active - Proposal to Strike off | |
SEREN PHOTONICS LIMITED | Director | 2012-03-06 | CURRENT | 2009-11-04 | Active - Proposal to Strike off | |
PHOTOPHARMICA LEEDS LIMITED | Director | 2011-09-22 | CURRENT | 2001-03-06 | Dissolved 2015-08-18 | |
FIRST LIGHT FUSION LIMITED | Director | 2011-06-30 | CURRENT | 2011-03-08 | Active | |
UNION LIFE SCIENCES LIMITED | Director | 2011-04-14 | CURRENT | 2006-02-16 | Active - Proposal to Strike off | |
ARKIVUM LIMITED | Director | 2011-03-24 | CURRENT | 2011-02-15 | Active | |
ANACAIL LIMITED | Director | 2011-02-23 | CURRENT | 2010-11-03 | Liquidation | |
CH4E LIMITED | Director | 2011-02-18 | CURRENT | 2009-01-07 | Dissolved 2016-10-27 | |
MBS DIRECTOR LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MBS SECRETARIAL LIMITED | Director | 2009-09-02 | CURRENT | 2007-05-23 | Active - Proposal to Strike off | |
MODERN BIOSCIENCES NOMINEES LIMITED | Director | 2009-08-04 | CURRENT | 2007-06-14 | Active | |
MODERN BIOSCIENCES LIMITED | Director | 2009-06-02 | CURRENT | 2005-04-05 | Active | |
C-CAPTURE LIMITED | Director | 2009-05-21 | CURRENT | 2009-05-21 | Active | |
AMAETHON LIMITED | Director | 2009-04-17 | CURRENT | 2003-07-30 | Liquidation | |
AZELLON LTD | Director | 2009-01-05 | CURRENT | 2007-12-07 | Active - Proposal to Strike off | |
POLAR OLED LTD | Director | 2008-11-26 | CURRENT | 2008-11-26 | Active - Proposal to Strike off | |
ENCOS LIMITED | Director | 2008-11-13 | CURRENT | 2007-04-23 | Dissolved 2017-04-11 | |
IKSUDA THERAPEUTICS LIMITED | Director | 2008-09-04 | CURRENT | 2007-11-21 | Active | |
DISPERSIA LIMITED | Director | 2008-08-01 | CURRENT | 2006-01-31 | Dissolved 2014-05-27 | |
DYECAT LIMITED | Director | 2008-08-01 | CURRENT | 2005-10-03 | Dissolved 2014-05-06 | |
CHAMELIC LIMITED | Director | 2008-08-01 | CURRENT | 2006-02-16 | Dissolved 2015-08-11 | |
STRUCTURE VISION LIMITED | Director | 2008-08-01 | CURRENT | 2003-03-20 | Active | |
SUSTAINABLE RESOURCE SOLUTIONS LIMITED | Director | 2008-07-25 | CURRENT | 2007-04-30 | Dissolved 2015-07-14 | |
RIO AI LIMITED | Director | 2008-04-09 | CURRENT | 1997-10-01 | Active | |
EMDOT LIMITED | Director | 2007-08-02 | CURRENT | 2007-08-02 | Active | |
MDL 2016 LIMITED | Director | 2007-02-22 | CURRENT | 2006-02-10 | Dissolved 2018-03-06 | |
SURREY NANOSYSTEMS LIMITED | Director | 2006-11-28 | CURRENT | 1999-06-02 | Active | |
PHARMINOX LIMITED | Director | 2006-09-15 | CURRENT | 2001-12-28 | Active - Proposal to Strike off | |
CAPSANT NEUROTECHNOLOGIES LIMITED | Director | 2006-06-28 | CURRENT | 2002-06-21 | Liquidation | |
MISSION THERAPEUTICS LIMITED | Director | 2013-10-10 | CURRENT | 2011-05-11 | Active |
Date | Document Type | Document Description |
---|---|---|
CONFIRMATION STATEMENT MADE ON 25/02/24, WITH UPDATES | ||
26/02/24 STATEMENT OF CAPITAL GBP 27436.375 | ||
APPOINTMENT TERMINATED, DIRECTOR ATUL CHANDRA PANDE | ||
23/11/23 STATEMENT OF CAPITAL GBP 27111.375 | ||
12/10/23 STATEMENT OF CAPITAL GBP 27086.375 | ||
GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/22 | ||
CONFIRMATION STATEMENT MADE ON 25/02/23, WITH UPDATES | ||
CONFIRMATION STATEMENT MADE ON 25/02/23, WITH UPDATES | ||
30/01/23 STATEMENT OF CAPITAL GBP 27056.375 | ||
SH01 | 30/01/23 STATEMENT OF CAPITAL GBP 27056.375 | |
CESSATION OF PFIZER INC AS A PERSON OF SIGNIFICANT CONTROL | ||
PSC07 | CESSATION OF PFIZER INC AS A PERSON OF SIGNIFICANT CONTROL | |
SH01 | 09/06/22 STATEMENT OF CAPITAL GBP 26990.375 | |
GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/21 | ||
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/21 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/22, WITH UPDATES | |
MR04 | STATEMENT OF SATISFACTION OF A CHARGE / FULL / CHARGE CODE 1 | |
PSC02 | Notification of Pfizer Inc as a person with significant control on 2021-11-01 | |
PSC07 | CESSATION OF SVLS LIFE SCIENCES FUND V LP AS A PERSON OF SIGNIFICANT CONTROL | |
PSC05 | Change of details for Touchstone Innovations Businesses Llp as a person with significant control on 2021-11-01 | |
SH01 | 08/06/21 STATEMENT OF CAPITAL GBP 26950.375 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/20 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/21, WITH UPDATES | |
SH01 | 18/01/21 STATEMENT OF CAPITAL GBP 26145.375 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/19 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/20, WITH UPDATES | |
SH01 | 31/07/19 STATEMENT OF CAPITAL GBP 25815.375 | |
SH01 | 31/05/19 STATEMENT OF CAPITAL GBP 38827.163 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/18 | |
AP01 | DIRECTOR APPOINTED RANA AL-HALLAQ | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ELAINE JONES | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/19, WITH UPDATES | |
CH01 | Director's details changed for Mr John Berriman on 2018-12-07 | |
SH01 | 21/09/18 STATEMENT OF CAPITAL GBP 25305.551 | |
SH06 | Cancellation of shares. Statement of capital on 2018-07-13 GBP 25,121.801 | |
RES09 | Resolution of authority to purchase a number of shares | |
SH03 | Purchase of own shares | |
SH06 | Cancellation of shares. Statement of capital on 2018-07-12 GBP 25,132.426 | |
SH03 | Purchase of own shares | |
AP02 | Appointment of Ip2Ipo Services Limited as director on 2018-03-12 | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR BOBBY G. SONI | |
PSC05 | Change of details for Imperial Innovations Businesses Llp as a person with significant control on 2018-02-02 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 30/09/17 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/18, WITH UPDATES | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / CHARLES LARGE / 01/02/2018 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR JOHN BERRIMAN / 01/02/2018 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
RES01 | ALTER ARTICLES 08/01/2018 | |
RES11 | Resolutions passed:
| |
AP01 | DIRECTOR APPOINTED MR BOBBY SONI | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR MAINA BHAMAN | |
LATEST SOC | 14/09/17 STATEMENT OF CAPITAL;GBP 26983.426 | |
SH01 | 22/08/17 STATEMENT OF CAPITAL GBP 26983.426 | |
AA01 | CURRSHO FROM 31/12/2017 TO 30/09/2017 | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/16 | |
LATEST SOC | 27/03/17 STATEMENT OF CAPITAL;GBP 26976.864 | |
SH01 | 07/03/17 STATEMENT OF CAPITAL GBP 26976.864 | |
LATEST SOC | 11/03/17 STATEMENT OF CAPITAL;GBP 26896.864 | |
CS01 | CONFIRMATION STATEMENT MADE ON 25/02/17, WITH UPDATES | |
AD01 | REGISTERED OFFICE CHANGED ON 23/02/2017 FROM IMPERIAL COLLEGE INCUBATOR LEVEL 1, BESSEMER BUILDING IMPERIAL COLLEGE LONDON SW7 2AZ UNITED KINGDOM | |
AA | GROUP OF COMPANIES' ACCOUNTS MADE UP TO 31/12/15 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / DR ATUL PANDE / 04/08/2016 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / MR JOHN BERRIMAN / 04/08/2016 | |
CH01 | DIRECTOR'S CHANGE OF PARTICULARS / CHARLES LARGE / 04/08/2016 | |
AD01 | REGISTERED OFFICE CHANGED ON 04/08/2016 FROM B205 IMPERIAL COLLEGE INCUBATOR LEVEL 1 BESSEMER BUILDING IMPERIAL COLLEGE LONDON SW7 2AZ | |
RES09 | AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL | |
RES09 | AUTHORITY- PURCHASE SHARES OTHER THAN FROM CAPITAL | |
RES01 | ALTER ARTICLES 17/05/2016 | |
RES01 | ALTER ARTICLES 17/05/2016 | |
LATEST SOC | 25/05/16 STATEMENT OF CAPITAL;GBP 26869.05 | |
SH06 | 17/05/16 STATEMENT OF CAPITAL GBP 26869.050 | |
SH01 | 17/05/16 STATEMENT OF CAPITAL GBP 26896.873 | |
LATEST SOC | 25/05/16 STATEMENT OF CAPITAL;GBP 26869.05 | |
SH03 | RETURN OF PURCHASE OF OWN SHARES | |
SH03 | RETURN OF PURCHASE OF OWN SHARES | |
SH01 | 28/04/16 STATEMENT OF CAPITAL GBP 26911.53 | |
SH01 | 28/04/16 STATEMENT OF CAPITAL GBP 26911.53 | |
LATEST SOC | 09/03/16 STATEMENT OF CAPITAL;GBP 26900.84 | |
AR01 | 25/02/16 FULL LIST | |
AR01 | 25/02/16 FULL LIST | |
SH01 | 30/09/15 STATEMENT OF CAPITAL GBP 33950.836 | |
LATEST SOC | 17/11/15 STATEMENT OF CAPITAL;GBP 33692.844 | |
SH01 | 14/10/15 STATEMENT OF CAPITAL GBP 33692.844 | |
AA | ACCOUNTS FOR 'SMALL' CO. MADE UP TO 31/12/14 | |
LATEST SOC | 25/06/15 STATEMENT OF CAPITAL;GBP 33549.443 | |
SH01 | 16/06/15 STATEMENT OF CAPITAL GBP 33549.443 | |
RES11 | DISAPPLICATION OF PRE-EMPTION RIGHTS | |
RES01 | ADOPT ARTICLES 16/06/2015 | |
SH01 | 05/06/15 STATEMENT OF CAPITAL GBP 19852.648 | |
AR01 | 25/02/15 FULL LIST | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR ALLAN BAXTER | |
AP01 | DIRECTOR APPOINTED DR ATUL PANDE | |
SH01 | 15/01/15 STATEMENT OF CAPITAL GBP 20106.05 | |
AA | FULL ACCOUNTS MADE UP TO 31/12/13 | |
LATEST SOC | 21/03/14 STATEMENT OF CAPITAL;GBP 19679.051 | |
AR01 | 25/02/14 FULL LIST | |
SH01 | 23/12/13 STATEMENT OF CAPITAL GBP 9770.053803 | |
MISC | CONSENT TO THE VARIATION OF RIGHTS ATTACHED TO THE SERIES A PREFERRED SHARE OF £0.001 EACH | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES13 | INCREASE COMPANY'S SHARE CAPITAL 11/10/2013 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH01 | 11/10/13 STATEMENT OF CAPITAL GBP 8936.85 | |
AA | 31/12/12 TOTAL EXEMPTION FULL | |
MEM/ARTS | ARTICLES OF ASSOCIATION | |
RES01 | ALTER ARTICLES 08/04/2013 | |
SH01 | 19/04/13 STATEMENT OF CAPITAL GBP 5938.630 | |
AP01 | DIRECTOR APPOINTED DR ELAINE JONES | |
AR01 | 25/02/13 FULL LIST | |
RES01 | ADOPT ARTICLES 14/02/2013 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH01 | 25/02/13 STATEMENT OF CAPITAL GBP 5533.63 | |
AAMD | AMENDED EXEMPTION FULL ACCOUNTS MADE UP TO 31/12/11 | |
SH01 | 19/11/12 STATEMENT OF CAPITAL GBP 13658.634 | |
SH01 | 09/10/12 STATEMENT OF CAPITAL GBP 5533.634 | |
AD01 | REGISTERED OFFICE CHANGED ON 12/10/2012 FROM 90 HIGH HOLBORN LONDON WC1V 6XX | |
AA | 31/12/11 TOTAL EXEMPTION FULL | |
SH01 | 06/02/12 STATEMENT OF CAPITAL GBP 5933.63 | |
SH01 | 23/12/11 STATEMENT OF CAPITAL GBP 5858.63 | |
AR01 | 25/02/12 FULL LIST | |
MG01 | PARTICULARS OF A MORTGAGE OR CHARGE / CHARGE NO: 1 | |
AP01 | DIRECTOR APPOINTED MR ALLAN BAXTER | |
AP01 | DIRECTOR APPOINTED MAINA BHAMAN | |
AP01 | DIRECTOR APPOINTED MRS CATHERINE ELIZABETH BINGHAM | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR GIUSEPPE ALVARO | |
AA01 | CURRSHO FROM 28/02/2012 TO 31/12/2011 | |
RES01 | ADOPT ARTICLES 19/08/2011 | |
RES10 | AUTHORISED ALLOTMENT OF SHARES AND DEBENTURES | |
SH01 | 19/08/11 STATEMENT OF CAPITAL GBP 4983.63 | |
SH01 | 05/08/11 STATEMENT OF CAPITAL GBP 1437.20 | |
RES15 | CHANGE OF NAME 23/05/2011 | |
CERTNM | COMPANY NAME CHANGED NEWINCCO 1091 LIMITED CERTIFICATE ISSUED ON 01/06/11 | |
CONNOT | NOTICE OF CHANGE OF NAME NM01 - RESOLUTION | |
SH02 | SUB-DIVISION 23/05/11 | |
SH01 | 23/05/11 STATEMENT OF CAPITAL GBP 1350.00 | |
SH01 | 23/05/11 STATEMENT OF CAPITAL GBP 1 | |
AP01 | DIRECTOR APPOINTED GIUSEPPE ALVARO | |
AP01 | DIRECTOR APPOINTED JOHN BERRIMAN | |
AP01 | DIRECTOR APPOINTED CHARLES LARGE | |
TM02 | APPOINTMENT TERMINATED, SECRETARY OLSWANG COSEC LIMITED | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 2 LIMITED | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR OLSWANG DIRECTORS 1 LIMITED | |
TM01 | APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER MACKIE | |
RES13 | SUB-DIVISION OF SHARES 23/05/2011 | |
NEWINC | CERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION |
Total # Mortgages/Charges | 1 |
---|---|
Mortgages/Charges outstanding | 0 |
Mortgages Partially Satisifed | 0 |
Mortgages Satisfied/Paid | 1 |
Charge Type | Date of Charge | Charge Status | Mortgagee |
---|---|---|---|
DEED OF CHARGE OVER CREDIT BALANCES | Outstanding | BARCLAYS BANK PLC |
|
|
These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on AUTIFONY THERAPEUTICS LIMITED
The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as AUTIFONY THERAPEUTICS LIMITED are:
Origin | Destination | Date | Import Code | Imported Goods classification description |
---|---|---|---|---|
84719000 | Magnetic or optical readers, machines for transcribing data onto data media in coded form and machines for processing such data, n.e.s. |
For goods imported into the United Kingdom, only imports originating from outside the EU are shown
Category | Award/Grant | |
---|---|---|
Development of a Kv3 Positive Modulator for the treatment of Schizophrenia : Feasibility Study | 2013-05-01 | £ 1,241,270 |
How is this useful? The company may be investing in new products to generate new revenue streams or investing in new technologies to increase productivity / reduce costs. The company may own IPR as a result.
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help. Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. |